{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T13:13:34Z","timestamp":1788614014654,"version":"build-2803163510"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Oncology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.seminoncol.2025.152436","type":"journal-article","created":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:05:03Z","timestamp":1762113903000},"page":"152436","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases"],"prefix":"10.1016","volume":"53","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3222-9454","authenticated-orcid":false,"given":"Rafi","family":"Aibani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir-Kabirian","family":"Borna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir","family":"Kamran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.seminoncol.2025.152436_bib0001","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cllc.2014.11.005","article-title":"Prophylactic cranial irradiation for patients with locally advanced non-small-cell lung cancer at high risk for brain metastases","volume":"16","author":"Park","year":"2015","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152436_bib0002","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152436_bib0003","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1200\/JCO.23.02219","article-title":"CNS efficacy of Osimertinib with or without chemotherapy in epidermal growth factor receptor-mutated advanced non-small-cell lung cancer","volume":"42","author":"J\u00e4nne","year":"2024","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.seminoncol.2025.152436_bib0004","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.912505","article-title":"Epidermal growth factor receptor mutations and brain metastases in non-small cell lung cancer","volume":"12","author":"Zhao","year":"2022","journal-title":"Front Oncol"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152436_bib0005","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s11060-017-2590-x","article-title":"High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases","volume":"135","author":"Ge","year":"2017","journal-title":"J Neurooncol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152436_bib0006","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/s41571-019-0320-3","article-title":"Current approaches to the management of brain metastases","volume":"17","author":"Suh","year":"2020","journal-title":"Nat Rev Clin Oncol"},{"issue":"20","key":"10.1016\/j.seminoncol.2025.152436_bib0007","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.1158\/1078-0432.CCR-16-0399","article-title":"Preclinical comparison of Osimertinib with other EGFR-TKIs in EGFR-mutant NSCLC brain metastases models, and early evidence of clinical brain metastases activity","volume":"22","author":"Ballard","year":"2016","journal-title":"Clin Cancer Res"},{"issue":"12","key":"10.1016\/j.seminoncol.2025.152436_bib0008","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1016\/j.jtho.2021.07.026","article-title":"A phase II study of Osimertinib for radiotherapy-naive central nervous system metastasis from NSCLC: results for the T790M cohort of the OCEAN study (LOGIK1603\/WJOG9116L)","volume":"16","author":"Yamaguchi","year":"2021","journal-title":"J Thorac Oncol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152436_bib0009","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1200\/JCO.21.02314","article-title":"Treatment for brain metastases: ASCO-SNO-ASTRO guideline","volume":"40","author":"Vogelbaum","year":"2022","journal-title":"J Clin Oncol"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152436_bib0010","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1200\/JCO.2016.69.7144","article-title":"Management of brain metastases in tyrosine kinase inhibitor-na\u00efve epidermal growth factor receptor-mutant non-small-cell lung cancer: a retrospective multi-institutional analysis","volume":"35","author":"Magnuson","year":"2017","journal-title":"J Clin Oncol"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152436_bib0011","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.radonc.2014.12.011","article-title":"EGFR tyrosine kinase inhibitors versus cranial radiation therapy for EGFR mutant non-small cell lung cancer with brain metastases: a systematic review and meta-analysis","volume":"114","author":"Soon","year":"2015","journal-title":"Radiother Oncol"},{"issue":"19","key":"10.1016\/j.seminoncol.2025.152436_bib0012","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1158\/1078-0432.CCR-13-0836","article-title":"A clinical model for identifying radiosensitive tumor genotypes in non-small cell lung cancer","volume":"19","author":"Johung","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.seminoncol.2025.152436_bib0013","doi-asserted-by":"crossref","DOI":"10.1177\/17588359231169975","article-title":"Rationale and value of consolidative cranial local therapy in EGFR-mutant non-small cell lung cancer patients with baseline brain metastasis treated with first-line EGFR-TKIs","volume":"15","author":"Zeng","year":"2023","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152436_bib0014","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1186\/s12885-023-11548-0","article-title":"First-line treatment with TKI plus brain radiotherapy versus TKI alone in EGFR-mutated non-small cell lung cancer with brain metastases: a systematic review and meta-analysis","volume":"23","author":"Song","year":"2023","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152436_bib0015","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/annonc\/mdi057","article-title":"Epidermal growth factor receptor signaling in colorectal cancer: preclinical data and therapeutic perspectives","volume":"16","author":"Spano","year":"2005","journal-title":"Ann Oncol"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152436_bib0016","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1093\/neuonc\/nov043","article-title":"Does lung cancer mutation status and targeted therapy predict for outcomes and local control in the setting of brain metastases treated with radiation?","volume":"17","author":"Wang","year":"2015","journal-title":"Neuro Oncol"},{"issue":"1","key":"10.1016\/j.seminoncol.2025.152436_bib0017","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0360-3016(03)00511-X","article-title":"The epidermal growth factor receptor mediates radioresistance","volume":"57","author":"Liang","year":"2003","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152436_bib0018","first-page":"3250","article-title":"Enhancement of antitumor activity of ionizing radiation by combined treatment with the selective epidermal growth factor receptor-tyrosine kinase inhibitor ZD1839 (Iressa)","volume":"8","author":"Bianco","year":"2002","journal-title":"Clin Cancer Res"},{"issue":"8","key":"10.1016\/j.seminoncol.2025.152436_bib0019","doi-asserted-by":"crossref","first-page":"3328","DOI":"10.1158\/0008-5472.CAN-04-3547","article-title":"Mechanisms of enhanced radiation response following epidermal growth factor receptor signaling inhibition by erlotinib (Tarceva)","volume":"65","author":"Chinnaiyan","year":"2005","journal-title":"Cancer Res"},{"issue":"35","key":"10.1016\/j.seminoncol.2025.152436_bib0020","doi-asserted-by":"crossref","first-page":"31182","DOI":"10.1074\/jbc.M506591200","article-title":"Radiation-induced epidermal growth factor receptor nuclear import is linked to activation of DNA-dependent protein kinase","volume":"280","author":"Dittmann","year":"2005","journal-title":"J Biol Chem"},{"issue":"2","key":"10.1016\/j.seminoncol.2025.152436_bib0021","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.radonc.2005.06.022","article-title":"Inhibition of radiation-induced EGFR nuclear import by C225 (Cetuximab) suppresses DNA-PK activity","volume":"76","author":"Dittmann","year":"2005","journal-title":"Radiother Oncol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152436_bib0022","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1016\/j.ijrobp.2008.10.026","article-title":"Phase I study of concurrent whole brain radiotherapy and erlotinib for multiple brain metastases from non-small-cell lung cancer","volume":"74","author":"Lind","year":"2009","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"7","key":"10.1016\/j.seminoncol.2025.152436_bib0023","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1200\/JCO.2011.40.1174","article-title":"Phase II trial of erlotinib plus concurrent whole-brain radiation therapy for patients with brain metastases from non-small-cell lung cancer","volume":"31","author":"Welsh","year":"2013","journal-title":"J Clin Oncol"},{"issue":"5","key":"10.1016\/j.seminoncol.2025.152436_bib0024","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1016\/j.ijrobp.2012.11.042","article-title":"A phase 3 trial of whole brain radiation therapy and stereotactic radiosurgery alone versus WBRT and SRS with temozolomide or erlotinib for non-small cell lung cancer and 1 to 3 brain metastases: radiation Therapy Oncology Group 0320","volume":"85","author":"Sperduto","year":"2013","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"10.1016\/j.seminoncol.2025.152436_bib0025","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1002\/ijc.28290","article-title":"The theoretical foundation and research progress for WBRT combined with erlotinib for the treatment of multiple brain metastases in patients with lung adenocarcinoma","volume":"133","author":"Zhuang","year":"2013","journal-title":"Int J Cancer"}],"updated-by":[{"DOI":"10.1016\/j.seminoncol.2026.152524","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T00:00:00Z","timestamp":1786492800000}},{"DOI":"10.1016\/j.seminoncol.2026.152524","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000}}],"container-title":["Seminars in Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0093775425001289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T13:47:04Z","timestamp":1768312024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0093775425001289"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S0093775425001289"],"URL":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152436","relation":{},"ISSN":["0093-7754"],"issn-type":[{"value":"0093-7754","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy of osimertinib with and without radiation therapy in EGFR-mutated nonsmall cell lung cancer with brain metastases","name":"articletitle","label":"Article Title"},{"value":"Seminars in Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.seminoncol.2025.152436","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152436"}}